Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics Releases its Annual Corporate Responsibility Report
06:00am, Friday, 10'th Sep 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients
09:54am, Tuesday, 07'th Sep 2021
United Therapeutics Corporation (NASDAQ: UTHR) has presented new clinical data from the BREEZE study evaluating Tyvaso DPI (treprostinil) in patients with pulmonary arterial hypertension (PAH). Rel
United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021
06:00am, Tuesday, 07'th Sep 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
Here's Why United Therapeutics Stock May Continue To Trend Higher
05:30am, Tuesday, 31'st Aug 2021
The stock price of United Therapeutics, a biotechnology company, has seen a rise of over 15% over the last twenty-one trading days, and it is up a solid 97% over the last twelve-month period. The rall
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021
06:00am, Tuesday, 24'th Aug 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
Liquidia: Martine Rothblatt's United Therapeutics Is Tough To Beat
09:42am, Monday, 09'th Aug 2021
Liquidia: Martine Rothblatt's United Therapeutics Is Tough To Beat
CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform Company
05:17pm, Thursday, 05'th Aug 2021
CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform Company
Why United Therapeutics Blasted 14% Higher Today
05:56pm, Wednesday, 04'th Aug 2021
Every one of the company's products booked a revenue gain in Q2.
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q2 2021 Results - Earnings Call Transcript
01:12pm, Wednesday, 04'th Aug 2021
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q2 2021 Results - Earnings Call Transcript
United Therapeutics (UTHR) Q2 Earnings and Revenues Surpass Estimates
08:24am, Wednesday, 04'th Aug 2021
United Therapeutics (UTHR) delivered earnings and revenue surprises of 27.62% and 17.66%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
United Therapeutics: Q2 Earnings Insights
07:10am, Wednesday, 04'th Aug 2021
Shares of United Therapeutics (NASDAQ:UTHR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 11.14% over the past year to $4.09, which beat the
United Therapeutics Corporation Reports Second Quarter 2021 Financial Results
06:00am, Wednesday, 04'th Aug 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021
06:00am, Wednesday, 28'th Jul 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study
06:00am, Wednesday, 30'th Jun 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
